» Articles » PMID: 34800438

FBXO7 Triggers Caspase 8-mediated Proteolysis of the Transcription Factor FOXO4 and Exacerbates Neuronal Cytotoxicity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2021 Nov 20
PMID 34800438
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is characterized by the progressive loss of midbrain dopamine neurons in the substantia nigra. Mutations in the F-box only protein 7 gene (Fbxo7) have been reported to cause an autosomal recessive form of early-onset familial PD. FBXO7 is a part of the SKP1-Cullin1-F-box (SCF) E3 ubiquitin ligase complex, which mediates ubiquitination of numerous substrates. FBXO7 also regulates mitophagy, cell growth, and proteasome activity. A member of the FOXO family, the transcription factor FOXO4, is also known to modulate several cellular responses, including cell cycle progression and apoptosis; however, the relationship between FBXO7 and FOXO4 has not been investigated. In this study, we determined that FBXO7 binds to FOXO4 and negatively regulates intracellular FOXO4 levels. Interestingly, we also found that FBXO7-mediated degradation of FOXO4 did not occur through either of two major proteolysis systems, the ubiquitin-proteasome system or the lysosome-autophagy pathway, although it was blocked by a caspase 8-specific inhibitor and caspase 8-knockdown. Moreover, intracellular FOXO4 levels were greatly reduced in dopaminergic MN9D cells following treatment with neurotoxic 6-hydroxydopamine (6-OHDA), which was produced upon FBXO7-mediated and caspase 8-mediated proteolysis. Taken together, these results suggest that FOXO4 is negatively regulated in FBXO7-linked PD through caspase 8 activation, suppressing the cytoprotective effect of FOXO4 during 6-OHDA-induced neuronal cell death.

Citing Articles

Caspase-8 in inflammatory diseases: a potential therapeutic target.

Zhang W, Zhu C, Liao Y, Zhou M, Xu W, Zou Z Cell Mol Biol Lett. 2024; 29(1):130.

PMID: 39379817 PMC: 11463096. DOI: 10.1186/s11658-024-00646-x.


FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma.

Luo L, Wu X, Fan J, Dong L, Wang M, Zeng Y Nat Commun. 2024; 15(1):4790.

PMID: 38839752 PMC: 11153525. DOI: 10.1038/s41467-024-49087-2.


USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.

Lee S, Chung K PLoS One. 2023; 18(10):e0290371.

PMID: 37874827 PMC: 10597484. DOI: 10.1371/journal.pone.0290371.


A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.

Fishman-Jacob T, Youdim M J Neural Transm (Vienna). 2023; 131(6):675-707.

PMID: 37644186 PMC: 11192832. DOI: 10.1007/s00702-023-02687-6.


Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells.

Harris R, Yang M, Schmidt C, Royet C, Singh S, Natarajan A J Cell Biol. 2022; 221(7).

PMID: 35670764 PMC: 9178409. DOI: 10.1083/jcb.202203095.

References
1.
Conedera S, Apaydin H, Li Y, Yoshino H, Ikeda A, Matsushima T . FBXO7 mutations in Parkinson's disease and multiple system atrophy. Neurobiol Aging. 2016; 40:192.e1-192.e5. DOI: 10.1016/j.neurobiolaging.2016.01.003. View

2.
Guicciardi M, Mott J, Bronk S, Kurita S, Fingas C, Gores G . Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Exp Cell Res. 2010; 317(1):107-16. PMC: 2991414. DOI: 10.1016/j.yexcr.2010.10.005. View

3.
Raza C, Anjum R, Shakeel N . Parkinson's disease: Mechanisms, translational models and management strategies. Life Sci. 2019; 226:77-90. DOI: 10.1016/j.lfs.2019.03.057. View

4.
Chung Y, Lee J, Jung S, Lee Y, Cho J, Oh Y . Dysregulated autophagy contributes to caspase-dependent neuronal apoptosis. Cell Death Dis. 2018; 9(12):1189. PMC: 6289995. DOI: 10.1038/s41419-018-1229-y. View

5.
Santo E, Paik J . FOXO in Neural Cells and Diseases of the Nervous System. Curr Top Dev Biol. 2018; 127:105-118. PMC: 5881381. DOI: 10.1016/bs.ctdb.2017.10.002. View